TY - JOUR AU - Thomas, C. F. J. AU - Limper, A. H. PY - 2004 DA - 2004// TI - Pneumocystis pneumonia JO - N Engl J Med. VL - 350 UR - https://doi.org/10.1056/NEJMra032588 DO - 10.1056/NEJMra032588 ID - Thomas2004 ER - TY - JOUR AU - Thomas, C. F. J. AU - Limper, A. H. PY - 2007 DA - 2007// TI - Current insights into the biology and pathogenesis of Pneumocystis pneumonia JO - Nat Rev Microbiol. VL - 5 UR - https://doi.org/10.1038/nrmicro1621 DO - 10.1038/nrmicro1621 ID - Thomas2007 ER - TY - JOUR PY - 1992 DA - 1992// TI - Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus JO - MMWR Recomm Rep VL - 41 ID - ref3 ER - TY - JOUR AU - Sepkowitz, K. A. AU - Brown, A. E. AU - Armstrong, D. PY - 1995 DA - 1995// TI - Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk JO - Arch Intern Med VL - 155 UR - https://doi.org/10.1001/archinte.1995.00430110015002 DO - 10.1001/archinte.1995.00430110015002 ID - Sepkowitz1995 ER - TY - JOUR AU - Hughes, W. T. AU - Feldman, S. AU - Aur, R. J. A. AU - Verzosa, M. S. AU - Hustu, H. O. AU - Simone, J. V. PY - 1975 DA - 1975// TI - Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis JO - Cancer. VL - 36 UR - https://doi.org/10.1002/cncr.2820360912 DO - 10.1002/cncr.2820360912 ID - Hughes1975 ER - TY - JOUR AU - Hardy, A. M. AU - Wajszczuk, C. P. AU - Suffredini, A. F. AU - Hakala, T. R. AU - Ho, M. PY - 1984 DA - 1984// TI - Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids JO - J Infect Dis. VL - 149 UR - https://doi.org/10.1093/infdis/149.2.143 DO - 10.1093/infdis/149.2.143 ID - Hardy1984 ER - TY - JOUR AU - Hofflin, J. M. AU - Potasman, I. AU - Baldwin, J. C. AU - Oyer, P. E. AU - Stinson, E. B. AU - Remington, J. S. PY - 1987 DA - 1987// TI - Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids JO - Ann Intern Med. VL - 106 UR - https://doi.org/10.7326/0003-4819-106-2-209 DO - 10.7326/0003-4819-106-2-209 ID - Hofflin1987 ER - TY - JOUR AU - Meyers, J. D. AU - Flournoy, N. AU - Thomas, E. D. PY - 1982 DA - 1982// TI - Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years’ experience JO - Rev Infect Dis. VL - 4 UR - https://doi.org/10.1093/clinids/4.6.1119 DO - 10.1093/clinids/4.6.1119 ID - Meyers1982 ER - TY - JOUR AU - Godeau, B. AU - Coutant-Perronne, V. AU - Thi, H. D. AU - Guillevin, L. AU - Magadur, G. AU - Bandt, M. PY - 1994 DA - 1994// TI - Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases JO - J Rheumatol. VL - 21 ID - Godeau1994 ER - TY - JOUR AU - Sepkowitz, K. A. PY - 2002 DA - 2002// TI - Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome JO - Clin Infect Dis. VL - 34 UR - https://doi.org/10.1086/339548 DO - 10.1086/339548 ID - Sepkowitz2002 ER - TY - JOUR AU - Komano, Y. AU - Harigai, M. AU - Koike, R. AU - Sugiyama, H. AU - Ogawa, J. AU - Saito, K. PY - 2009 DA - 2009// TI - Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients JO - Arthritis Care Res. VL - 61 UR - https://doi.org/10.1002/art.24283 DO - 10.1002/art.24283 ID - Komano2009 ER - TY - JOUR AU - Watanabe, K. AU - Sakai, R. AU - Koike, R. AU - Sakai, F. AU - Sugiyama, H. AU - Tanaka, M. PY - 2013 DA - 2013// TI - Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients JO - Mod Rheumatol. VL - 23 UR - https://doi.org/10.3109/s10165-012-0796-5 DO - 10.3109/s10165-012-0796-5 ID - Watanabe2013 ER - TY - JOUR AU - Tanaka, M. AU - Sakai, R. AU - Koike, R. AU - Komano, Y. AU - Nanki, T. AU - Sakai, F. PY - 2012 DA - 2012// TI - Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors JO - Mod Rheumatol. VL - 22 UR - https://doi.org/10.3109/s10165-012-0615-z DO - 10.3109/s10165-012-0615-z ID - Tanaka2012 ER - TY - JOUR AU - Tanaka, M. AU - Sakai, R. AU - Koike, R. AU - Harigai, M. PY - 2015 DA - 2015// TI - Pneumocystis Jirovecii pneumonia in Japanese patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a pooled analysis of 3 agents JO - J Rheumatol. VL - 42 UR - https://doi.org/10.3899/jrheum.141510 DO - 10.3899/jrheum.141510 ID - Tanaka2015 ER - TY - JOUR AU - Roux, A. AU - Gonzalez, F. AU - Roux, M. AU - Mehrad, M. AU - Menotti, J. AU - Zahar, J. R. PY - 2014 DA - 2014// TI - Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients JO - Med Mal Infect. VL - 44 UR - https://doi.org/10.1016/j.medmal.2014.01.007 DO - 10.1016/j.medmal.2014.01.007 ID - Roux2014 ER - TY - JOUR AU - Khanna, D. AU - McMahon, M. AU - Furst, D. E. PY - 2004 DA - 2004// TI - Safety of tumour necrosis factor-α antagonists JO - Drug Saf. VL - 27 UR - https://doi.org/10.2165/00002018-200427050-00003 DO - 10.2165/00002018-200427050-00003 ID - Khanna2004 ER - TY - JOUR AU - Harigai, M. AU - Koike, R. AU - Miyasaka, N. PY - 2007 DA - 2007// TI - Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group. Pneumocystis pneumonia associated with infliximab in Japan JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMc070728 DO - 10.1056/NEJMc070728 ID - Harigai2007 ER - TY - JOUR AU - Takeuchi, T. AU - Tatsuki, Y. AU - Nogami, Y. AU - Ishiguro, N. AU - Tanaka, Y. AU - Yamanaka, H. PY - 2008 DA - 2008// TI - Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis JO - Ann Rheum Dis. VL - 67 UR - https://doi.org/10.1136/ard.2007.072967 DO - 10.1136/ard.2007.072967 ID - Takeuchi2008 ER - TY - JOUR AU - Yamazaki, H. AU - Sakai, R. AU - Koike, R. AU - Miyazaki, Y. AU - Tanaka, M. AU - Watanabe, K. PY - 2015 DA - 2015// TI - Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study JO - J Rheumatol. VL - 42 UR - https://doi.org/10.3899/jrheum.140778 DO - 10.3899/jrheum.140778 ID - Yamazaki2015 ER - TY - JOUR AU - Yale, S. H. AU - Limper, A. H. PY - 1996 DA - 1996// TI - Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy JO - Mayo Clin Proc. VL - 71 UR - https://doi.org/10.4065/71.1.5 DO - 10.4065/71.1.5 ID - Yale1996 ER - TY - JOUR AU - Kovacs, J. A. AU - Hiemenz, J. W. AU - Macher, A. M. AU - Stover, D. AU - Murray, H. W. AU - Shelhamer, J. PY - 1984 DA - 1984// TI - Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies JO - Ann Intern Med. VL - 100 UR - https://doi.org/10.7326/0003-4819-100-5-663 DO - 10.7326/0003-4819-100-5-663 ID - Kovacs1984 ER - TY - JOUR AU - Ioannidis, J. P. AU - Cappelleri, J. C. AU - Skolnik, P. R. AU - Lau, J. AU - Sacks, H. S. PY - 1996 DA - 1996// TI - A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens JO - Arch Intern Med. VL - 156 UR - https://doi.org/10.1001/archinte.1996.00440020081010 DO - 10.1001/archinte.1996.00440020081010 ID - Ioannidis1996 ER - TY - JOUR AU - Ogawa, J. AU - Harigai, M. AU - Nagasaka, K. AU - Nakamura, T. AU - Miyasaka, N. PY - 2005 DA - 2005// TI - Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy JO - Mod Rheumatol. VL - 15 UR - https://doi.org/10.3109/PL00021707 DO - 10.3109/PL00021707 ID - Ogawa2005 ER - TY - STD TI - Kovacs JA. Pneumocystis Pneumonia. In: Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. Philadelphia: Elsevier; 2016. p. 2091–2099.e3. ID - ref24 ER - TY - JOUR AU - Hardy, W. D. AU - Feinberg, J. AU - Finkelstein, D. M. AU - Power, M. E. AU - He, W. AU - Kaczka, C. PY - 1992 DA - 1992// TI - A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021 JO - N Engl J Med VL - 327 UR - https://doi.org/10.1056/NEJM199212243272604 DO - 10.1056/NEJM199212243272604 ID - Hardy1992 ER - TY - JOUR AU - Schneider, M. M. AU - Nielsen, T. L. AU - Nelsing, S. AU - Hoepelman, A. I. AU - Eeftinck Schattenkerk, J. K. AU - Graaf, Y. PY - 1995 DA - 1995// TI - Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment Group JO - J Infect Dis VL - 171 UR - https://doi.org/10.1093/infdis/171.6.1632 DO - 10.1093/infdis/171.6.1632 ID - Schneider1995 ER - TY - JOUR AU - Fischl, M. A. AU - Dickinson, G. M. AU - Voie, L. PY - 1988 DA - 1988// TI - Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS JO - JAMA. VL - 259 UR - https://doi.org/10.1001/jama.259.8.1185 DO - 10.1001/jama.259.8.1185 ID - Fischl1988 ER - TY - JOUR AU - Green, H. AU - Paul, M. AU - Vidal, L. AU - Leibovici, L. PY - 2007 DA - 2007// TI - Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials JO - Mayo Clin Proc. VL - 82 UR - https://doi.org/10.4065/82.9.1052 DO - 10.4065/82.9.1052 ID - Green2007 ER - TY - JOUR AU - Smilack, J. D. PY - 1999 DA - 1999// TI - Trimethoprim-sulfamethoxazole JO - Mayo Clin Proc. VL - 74 UR - https://doi.org/10.4065/74.7.730 DO - 10.4065/74.7.730 ID - Smilack1999 ER - TY - JOUR AU - Howe, R. A. AU - Spencer, R. C. PY - 1996 DA - 1996// TI - Cotrimoxazole. Rationale for re-examining its indications for use JO - Drug Saf VL - 14 UR - https://doi.org/10.2165/00002018-199614040-00001 DO - 10.2165/00002018-199614040-00001 ID - Howe1996 ER - TY - JOUR AU - Jick, H. AU - Derby, L. E. PY - 1995 DA - 1995// TI - A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity JO - Pharmacotherapy. VL - 15 ID - Jick1995 ER - TY - JOUR AU - Kimura, M. AU - Tanaka, S. AU - Ishikawa, A. AU - Endo, H. AU - Hirohata, S. AU - Kondo, H. PY - 2008 DA - 2008// TI - Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease JO - Rheumatol Int. VL - 28 UR - https://doi.org/10.1007/s00296-007-0505-4 DO - 10.1007/s00296-007-0505-4 ID - Kimura2008 ER - TY - JOUR AU - Takenaka, K. AU - Komiya, Y. AU - Ota, M. AU - Yamazaki, H. AU - Nagasaka, K. PY - 2013 DA - 2013// TI - A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases JO - Mod Rheumatol. VL - 23 UR - https://doi.org/10.3109/s10165-012-0730-x DO - 10.3109/s10165-012-0730-x ID - Takenaka2013 ER - TY - JOUR AU - Clopper, C. AU - Pearson, E. S. PY - 1934 DA - 1934// TI - The use of confidence or fiducial limits illustrated in the case of the binomial JO - Biometrika. VL - 26 UR - https://doi.org/10.1093/biomet/26.4.404 DO - 10.1093/biomet/26.4.404 ID - Clopper1934 ER - TY - JOUR AU - Hanley, J. A. AU - Lippman-Hand, A. PY - 1983 DA - 1983// TI - If nothing goes wrong, is everything all right? Interpreting zero numerators JO - JAMA. VL - 249 UR - https://doi.org/10.1001/jama.1983.03330370053031 DO - 10.1001/jama.1983.03330370053031 ID - Hanley1983 ER - TY - JOUR AU - Eypasch, E. AU - Lefering, R. AU - Kum, C. K. AU - Troidl, H. PY - 1995 DA - 1995// TI - Probability of adverse events that have not yet occurred: a statistical reminder JO - BMJ. VL - 311 UR - https://doi.org/10.1136/bmj.311.7005.619 DO - 10.1136/bmj.311.7005.619 ID - Eypasch1995 ER - TY - JOUR AU - Vananuvat, P. AU - Suwannalai, P. AU - Sungkanuparph, S. AU - Limsuwan, T. AU - Ngamjanyaporn, P. AU - Janwityanujit, S. PY - 2011 DA - 2011// TI - Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases JO - Semin Arthritis Rheum. VL - 41 UR - https://doi.org/10.1016/j.semarthrit.2011.05.004 DO - 10.1016/j.semarthrit.2011.05.004 ID - Vananuvat2011 ER -